Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients

被引：0

作者：

Bellosillo, Beatriz ^{[1
]}

Dahnases, Alba ^{[1
]}

Martinez, Alejandro ^{[1
]}

Iglesias, Mar ^{[1
]}

Gonzalez, Irio ^{[1
]}

Salido, Marta ^{[1
]}

Busto, Marcos ^{[1
]}

Sanchez, Juan ^{[1
]}

Vidal, Joana ^{[1
]}

Clave, Sergi ^{[1
]}

Moragon, Ester ^{[1
]}

Pairet, Silvia ^{[1
]}

Bellmunt, Joaquim ^{[1
]}

Serrano, Sergio ^{[1
]}

Rovira, Ana ^{[1
]}

Albanell, Joan ^{[1
]}

Montagut, Clara ^{[1
]}

机构：

[1] Hosp del Mar, Barcelona, Spain

来源：

LABORATORY INVESTIGATION | 2015年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

583

引用

页码：148A / 148A

页数：1

共 50 条

[21] Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
E. J. van Helden
C. W. Menke-van der Houven van Oordt
M. W. Heymans
J. C. F. Ket
R. van den Oord
H. M. W. Verheul
Cancer and Metastasis Reviews, 2017, 36 : 395 - 406
[22] Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer
Kasi, Pashtoon Murtaza
Afable, Manuel Geroy
Herting, Cameron
Lukanowski, Mariusz
Jin, Zhaohui
ONCOLOGIST, 2023, : 1034 - 1048
[23] Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
Bertotti, Andrea
Sassi, Francesco
CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3377 - 3383
[24] Concomitant blockade of EGFR and MEK overcomes acquired resistance to anti-EGFR therapy in colorectal cancer cells and patients' avatars
Bardelli, Alberto
Misale, Sandra
Arena, Sabrina
Siravegna, Giulia
Lamba, Simona
Bencardino, Katia
Amatu, Alessio
Valtorta, Emanuele
Lauricella, Calogero
Sarlore-Bianchi, Andrea
Di Nicolantonio, Federica
Siena, Salvatore
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[25] Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab
Napolitano, Stefania
Martini, Giulia
Rinaldi, Barbara
Martinelli, Erika
Donniacuo, Maria
Berrino, Liberato
Vitagliano, Donata
Morgillo, Floriana
Barra, Giusy
De Palma, Raffaele
Merolla, Francesco
Ciardiello, Fortunato
Troiani, Teresa
CLINICAL CANCER RESEARCH, 2015, 21 (13) : 2975 - 2983
[26] RAS mutations as markers of resistance for colorectal cancer patients treated with the anti-EGFR monoclonal antibody panitumumab
Oliner, K.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S8
[27] Overcoming the Hurdles: Surmounting Acquired Resistance to Anti-EGFR Therapy in Metastatic Colorectal Cancer
Sackstein, Paul E.
Chintapally, Nikita
Wilgucki, Molly
Hartley, Marion L.
Alqahtani, Ali
Weinberg, Benjamin A.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (11) : 572 - 583
[28] The secondary mutation of KRAS and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer
Xia, X.
Du, W.
Zhu, Y.
Bai, Y.
Liu, M.
CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (3-4) : 218 - 218
[29] Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
Rios-Hoyo, Alejandro
Monzonis, Xavier
Vidal, Joana
Linares, Jenniffer
Montagut, Clara
FRONTIERS IN PHARMACOLOGY, 2024, 15
[30] Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
Misale, Sandra
Arena, Sabrina
Lamba, Simona
Siravegna, Giulia
Lallo, Alice
Hobor, Sebastijan
Russo, Mariangela
Buscarino, Michela
Lazzari, Luca
Sartore-Bianchi, Andrea
Bencardino, Katia
Amatu, Alessio
Lauricella, Calogero
Valtorta, Emanuele
Siena, Salvatore
Di Nicolantonio, Federica
Bardelli, Alberto
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

← 1 2 3 4 5 →